Editas Medicine, Inc.

EDIT

$4.15

Name : Editas Medicine, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $373,168,672.00

EPSttm : -2.84

Editas Medicine, Inc.

$4.15

5.60%

$0.22

Float Short %

8.49

Margin Of Safety %

Put/Call OI Ratio

0.06

EPS Next Q Diff

0.37

EPS Last/This Y

0.88

EPS This/Next Y

1.08

Price

4.15

Target Price

Analyst Recom

2.43

Performance Q

35.62

Relative Volume

2.65

Beta

2.23

Ticker: EDIT

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	EDIT	2.79	0.07	0.11	46712
2025-09-09	EDIT	2.76	0.07	0.03	46829
2025-09-10	EDIT	2.56	0.07	0.21	46747
2025-09-11	EDIT	2.7	0.07	0.40	46766
2025-09-12	EDIT	2.68	0.08	0.44	47102
2025-09-15	EDIT	2.66	0.08	0.03	47108
2025-09-16	EDIT	2.83	0.08	0.11	47149
2025-09-17	EDIT	2.72	0.075189165852439	0.31277533039648	47318
2025-09-18	EDIT	2.99	0.08	0.03	47517
2025-09-22	EDIT	2.99	0.07	0.03	44993
2025-09-23	EDIT	3.02	0.07	0.02	45789
2025-09-24	EDIT	3.38	0.07	0.05	46219
2025-09-25	EDIT	3.23	0.07	0.01	47497
2025-09-26	EDIT	3.23	0.06	0.29	48411
2025-09-29	EDIT	3.52	0.07	0.01	48458
2025-09-30	EDIT	3.46	0.07	0.15	49267
2025-10-01	EDIT	3.55	0.07	0.16	49479
2025-10-02	EDIT	3.88	0.07	0.01	49403
2025-10-03	EDIT	3.92	0.06	0.01	52650
2025-10-06	EDIT	3.81	0.06	0.02	51979
2025-10-07	EDIT	3.93	0.06	0.03	52068
2025-10-08	EDIT	4.15	0.06	0.03	51979
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	EDIT	2.79	51.4	-	-2.00
2025-09-09	EDIT	2.76	51.4	-	-2.00
2025-09-10	EDIT	2.57	51.4	-	-2.00
2025-09-11	EDIT	2.71	51.4	-	-2.00
2025-09-12	EDIT	2.68	51.4	-	-2.00
2025-09-15	EDIT	2.66	51.4	-	-2.00
2025-09-16	EDIT	2.83	51.4	-	-2.00
2025-09-17	EDIT	2.72	51.4	-	-2.00
2025-09-18	EDIT	2.99	51.4	-	-2.00
2025-09-19	EDIT	2.83	51.4	-	-2.00
2025-09-22	EDIT	3.00	51.4	-	-2.00
2025-09-23	EDIT	3.01	51.4	-	-2.00
2025-09-24	EDIT	3.38	51.4	-	-2.00
2025-09-25	EDIT	3.23	51.4	-	-2.00
2025-09-26	EDIT	3.24	51.4	-	-2.00
2025-09-29	EDIT	3.52	48.7	-	-2.00
2025-09-30	EDIT	3.47	48.7	-	-2.00
2025-10-01	EDIT	3.55	48.7	-	-2.00
2025-10-02	EDIT	3.88	48.7	-	-2.00
2025-10-03	EDIT	3.92	48.7	-	-2.00
2025-10-06	EDIT	3.81	48.7	-	-2.00
2025-10-07	EDIT	3.94	48.7	-	-2.00
2025-10-08	EDIT	4.15	48.7	-	-2.00
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

23 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	EDIT	-3.45	-6.01	9.21
2025-09-09	EDIT	-3.45	-6.01	9.21
2025-09-10	EDIT	-3.45	-6.01	9.21
2025-09-11	EDIT	-3.45	-6.01	8.77
2025-09-12	EDIT	-3.45	-6.01	8.77
2025-09-15	EDIT	-3.45	-5.67	8.77
2025-09-16	EDIT	-3.45	-5.67	8.77
2025-09-17	EDIT	-3.45	-5.67	8.77
2025-09-18	EDIT	-3.45	-5.67	8.77
2025-09-19	EDIT	-3.45	-5.67	8.77
2025-09-22	EDIT	-3.45	-5.70	8.77
2025-09-23	EDIT	-3.45	-5.70	8.77
2025-09-24	EDIT	-3.45	-5.70	8.77
2025-09-25	EDIT	-3.45	-5.70	8.49
2025-09-26	EDIT	-3.45	-5.70	8.49
2025-09-29	EDIT	-3.45	-5.67	8.49
2025-09-30	EDIT	-3.45	-5.67	8.49
2025-10-01	EDIT	-3.45	-5.67	8.49
2025-10-02	EDIT	-3.45	-5.67	8.49
2025-10-03	EDIT	-3.45	-5.67	8.49
2025-10-06	EDIT	-3.45	-2.77	8.49
2025-10-07	EDIT	-3.45	-2.77	8.49
2025-10-08	EDIT	-3.45	-2.77	8.49
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

23 items 1 of 1

Last Quarter Act. EPS

-0.63

Avg. EPS Est. Current Quarter

-0.38

Avg. EPS Est. Next Quarter

-0.26

Insider Transactions

-3.45

Institutional Transactions

-2.77

Beta

2.23

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

95.9

Max Drawdown 5-Year %

-98.9

Target Price

P/E

Forward P/E

PEG

P/S

9.59

P/B

18.9

P/Free Cash Flow

EPS

-2.85

Average EPS Est. Cur. Y

-2

EPS Next Y. (Est.)

-0.93

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-608.88

Relative Volume

2.65

Return on Equity vs Sector %

-1259.6

Return on Equity vs Industry %

-1245.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

Editas Medicine, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 246

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.

stock quote shares EDIT – Editas Medicine, Inc. Stock Price stock today

news today EDIT – Editas Medicine, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch EDIT – Editas Medicine, Inc. yahoo finance google finance

stock history EDIT – Editas Medicine, Inc. invest stock market

stock prices EDIT premarket after hours

ticker EDIT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: EDIT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y